New Products

Delafloxacin (Baxdela) for Acute Bacterial Skin Infections
Delafloxacin (Baxdela) for Acute Bacterial Skin InfectionsDelafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.
First Drug with an Ingestible Sensor ApprovedAbilify MyCite is the first drug to contain a bit of technology that reports that it has been taken as prescribed.
Edaravone (Radicava) for ALS
Edaravone (Radicava) for ALSEdaravone has been approved for patients with amyotropic lateral sclerosis.
Ocrelizumab for Multiple Sclerosis
Ocrelizumab for Multiple SclerosisThe FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
New Drug Review: Sarilumab
New Drug Review: SarilumabThe FDA approved Kevzara for RA patients.
Omnicell System Streamlines Medication ManagementNew technology is helping patients, nurses, and pharmacists alike.
Surescripts Expands Medication History ServiceMore information could help save lives.
New Product Uses Dual Approach to Dissolve Cerumen
New Product Uses Dual Approach to Dissolve CerumenNew product uses new technology to break down earwax
New Drug ReviewPlecanatide: Approved for Chronic Idiopathic Constipation